Mechanisms controlling the effects of bevacizumab (avastin) on the inhibition of early but not late formed corneal neovascularization.
PURPOSE: To evaluate the effects and underlying mechanisms of early and late subconjunctival injection of bevacizumab on the inhibition of corneal neovascularization (NV). METHODS: Corneal NV was induced by closed eye contact lens wear followed by a silk suture tarsorrhaphy in rabbits. Weekly subcon...
Main Authors: | Wei-Li Chen, Yan-Ming Chen, Hsiao-Sang Chu, Chung-Tien Lin, Lu-Ping Chow, Chih-Ta Chen, Fung-Rong Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3979754?pdf=render |
Similar Items
-
Inhibitory Effect of Anti-VEGF Drugs Bevacizumab (Avastin) on Corneal Neovascularization
by: Nien-Ting Lin, et al.
Published: (2008) -
Intravitreal Bevacizumab (Avastin) Injection for Neovascular Glaucoma
by: Shahin Yazdani, et al.
Published: (2008-12-01) -
Bevacizumab (Avastin®) for the management of anterior chamber neovascularization and neovascular glaucoma
by: Dimitrios Brouzas, et al.
Published: (2009-11-01) -
Intravitreal bevacizumab (Avastin) in choroidal neovascular membrane in angioid streaks
by: Sachdev Nishant, et al.
Published: (2007-01-01) -
Bevacizumab (Avastin) and Thermal Laser Combination Therapy for Peripapillary Choroidal Neovascular Membranes
by: Sean D. Adrean, et al.
Published: (2017-01-01)